Should You Buy Oscar Health, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Oscar Health, Inc. (OSCR) carries a solid Quality of Company rating of 7.1/10. Trading at $32.44, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.
The short answer: 1 of 3 CirclFi valuation models project upside for Oscar Health, Inc. (OSCR) at $32.44 — the model consensus leans bearish, with a Quality Score of 7.1/10 and Value-Trap risk of 24/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Oscar Health, Inc. (OSCR) in 2026?
What Is the Bull Case vs the Bear Case for Oscar Health, Inc. (OSCR)?
| Bull case — $56.38 target (+73.8%) | Bear case — $16.31 target (-49.7%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Oscar Health, Inc.'s quality score of 7.1/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation. | According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $16.31 (-49.7%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the FTNN Topology model targets a fair value of $56.38 (+73.8%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +123.5% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
| Industry tailwind: licensing and M&A optionality could provide meaningful support for Oscar Health, Inc.'s revenue and margin trajectory in the Healthcare Plans space. | Industry headwind: generic/biosimilar competition represents a meaningful risk for Oscar Health, Inc. and its Healthcare Plans peers. |
How Does OSCR Compare to Its Healthcare Plans Peers?
Valuation data pages: ALHC · CLOV · CNC · MRAI · CVS · PGNY · UNH · HUM · PFHO
Which Other Stocks Score Like OSCR on Quality?
Closest companies to OSCR’s Quality of Company score of 7.1/10, across all industries.
- MS — Morgan Stanley (QOC 7.1) · analysis
- EBS — Emergent BioSolutions Inc. (QOC 7.1) · analysis
- NMR — Nomura Holdings, Inc. (QOC 7.1) · analysis
- ASTH — Astrana Health, Inc. (QOC 7.1) · analysis
- MTH — Meritage Homes Corporation (QOC 7.1) · analysis
- AOUT — American Outdoor Brands, Inc. (QOC 7.1) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is Oscar Health, Inc. (OSCR) Worth Buying in 2026?
Caution dominates our read on Oscar Health, Inc. at $32.44. 2 of 3 models see limited upside or outright downside, with the median fair value at $30.55 (-5.8%). Quality at 7.1/10 provides some fundamental cushion. Current holders should re-evaluate their thesis; new buyers should demand a wider margin of safety.
These are quantitative model outputs, not investment recommendations. Oscar Health, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About OSCR Stock?
Should I buy OSCR stock right now?
Based on CirclFi's multi-model analysis, 1 of 3 models see upside for OSCR at $32.44. The models are divided, which means the investment case depends heavily on your assumptions about Oscar Health, Inc.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Oscar Health, Inc.?
Key risks include: limited model coverage (3/13 active), reducing analytical confidence; wide model disagreement (246% spread), signaling high uncertainty; general market and sector-specific risks affecting Healthcare Plans companies. Always diversify and consult a financial advisor.
How does OSCR compare to its competitors?
Among Healthcare Plans peers, OSCR holds a Quality Score of 7.1/10. Comparable companies include ALHC (QOC 7.2), CLOV (QOC 6.5), CNC (QOC 7.4). The relative ranking helps investors identify whether OSCR offers better fundamental quality than alternatives in the same sector.
Is OSCR a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. OSCR's Quality Score of 7.1/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy OSCR at?
CirclFi does not provide target buy prices or price alerts. However, our 3 active models produce fair value estimates ranging from $16.31 to $56.38. At $32.44, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for OSCR.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad